Page last updated: 2024-09-03

cp 115953 and histidine

cp 115953 has been researched along with histidine in 1 studies

Compound Research Comparison

Studies (cp 115953)	Trials (cp 115953)	Recent Studies (post-2010) (cp 115953)	Studies (histidine)	Trials (histidine)	Recent Studies (post-2010) (histidine)
20	0	0	22,046	114	4,371

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Elsea, SH; Hsiung, Y; Nitiss, JL; Osheroff, N	1

Other Studies

1 other study(ies) available for cp 115953 and histidine

Article	Year
A yeast type II topoisomerase selected for resistance to quinolones. Mutation of histidine 1012 to tyrosine confers resistance to nonintercalative drugs but hypersensitivity to ellipticine. The Journal of biological chemistry, 1995, Jan-27, Volume: 270, Issue:4 Topics: Amino Acid Sequence; Animals; Anti-Infective Agents; DNA Topoisomerases, Type II; Drug Resistance; Ellipticines; Fluoroquinolones; Histidine; Humans; Kinetics; Mice; Molecular Sequence Data; Mutagenesis, Site-Directed; Point Mutation; Quinolones; Recombinant Proteins; Saccharomyces cerevisiae; Sequence Homology, Amino Acid; Topoisomerase II Inhibitors; Tyrosine	1995

Article

Year

A yeast type II topoisomerase selected for resistance to quinolones. Mutation of histidine 1012 to tyrosine confers resistance to nonintercalative drugs but hypersensitivity to ellipticine.

The Journal of biological chemistry, 1995, Jan-27, Volume: 270, Issue:4

Topics: Amino Acid Sequence; Animals; Anti-Infective Agents; DNA Topoisomerases, Type II; Drug Resistance; Ellipticines; Fluoroquinolones; Histidine; Humans; Kinetics; Mice; Molecular Sequence Data; Mutagenesis, Site-Directed; Point Mutation; Quinolones; Recombinant Proteins; Saccharomyces cerevisiae; Sequence Homology, Amino Acid; Topoisomerase II Inhibitors; Tyrosine

1995